Sensitization of Pancreatic Cancers to Gemcitabine Chemoradiation by WEE1 Kinase Inhibition Depends on Homologous Recombination Repair()()

To improve the efficacy of chemoradiation therapy for locally advanced pancreatic cancer and begin to establish patient selection criteria, we investigated the combination of the WEE1 inhibitor AZD1775 with gemcitabine-radiation in homologous recombination (HR) repair proficient and deficient pancre...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neoplasia
Autori principali: Kausar, Tasneem, Schreiber, Jason S., Karnak, David, Parsels, Leslie A., Parsels, Joshua D., Davis, Mary A., Zhao, Lili, Maybaum, Jonathan, Lawrence, Theodore S., Morgan, Meredith A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Neoplasia Press 2015
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4656803/
https://ncbi.nlm.nih.gov/pubmed/26585231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2015.09.006
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi